Num | GO | Overlap | Size | P Value | Adj. P Value |
1 |
REGULATION OF CELL DIFFERENTIATION |
215 |
1492 |
2.465e-28 |
1.147e-24 |
2 |
REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT |
231 |
1672 |
7.826e-28 |
1.821e-24 |
3 |
NEUROGENESIS |
187 |
1402 |
1.166e-20 |
1.808e-17 |
4 |
BIOLOGICAL ADHESION |
148 |
1032 |
2.885e-19 |
3.356e-16 |
5 |
POSITIVE REGULATION OF DEVELOPMENTAL PROCESS |
157 |
1142 |
1.274e-18 |
1.186e-15 |
6 |
REGULATION OF CELL DEVELOPMENT |
126 |
836 |
3.027e-18 |
2.348e-15 |
7 |
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
213 |
1784 |
9.828e-18 |
6.533e-15 |
8 |
POSITIVE REGULATION OF CELL DIFFERENTIATION |
122 |
823 |
4.049e-17 |
2.355e-14 |
9 |
RESPONSE TO ENDOGENOUS STIMULUS |
180 |
1450 |
1.184e-16 |
6.12e-14 |
10 |
NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS |
118 |
801 |
2.222e-16 |
1.034e-13 |
11 |
NEURON DIFFERENTIATION |
125 |
874 |
2.783e-16 |
1.177e-13 |
12 |
CARDIOVASCULAR SYSTEM DEVELOPMENT |
116 |
788 |
4.294e-16 |
1.537e-13 |
13 |
CIRCULATORY SYSTEM DEVELOPMENT |
116 |
788 |
4.294e-16 |
1.537e-13 |
14 |
REGULATION OF CELLULAR COMPONENT MOVEMENT |
114 |
771 |
5.677e-16 |
1.887e-13 |
15 |
BEHAVIOR |
87 |
516 |
8.675e-16 |
2.691e-13 |
16 |
SINGLE ORGANISM BEHAVIOR |
72 |
384 |
1.051e-15 |
2.876e-13 |
17 |
CELL DEVELOPMENT |
175 |
1426 |
1.016e-15 |
2.876e-13 |
18 |
CELLULAR RESPONSE TO ENDOGENOUS STIMULUS |
133 |
1008 |
1.862e-14 |
4.814e-12 |
19 |
REGULATION OF NEURON DIFFERENTIATION |
88 |
554 |
2.228e-14 |
5.184e-12 |
20 |
REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS |
134 |
1021 |
2.225e-14 |
5.184e-12 |
21 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
130 |
983 |
3.174e-14 |
7.033e-12 |
22 |
POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
167 |
1395 |
4.689e-14 |
9.917e-12 |
23 |
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
106 |
740 |
5.389e-14 |
1.09e-11 |
24 |
MOVEMENT OF CELL OR SUBCELLULAR COMPONENT |
156 |
1275 |
5.858e-14 |
1.136e-11 |
25 |
CENTRAL NERVOUS SYSTEM DEVELOPMENT |
118 |
872 |
1.091e-13 |
2.031e-11 |
26 |
HEAD DEVELOPMENT |
102 |
709 |
1.258e-13 |
2.252e-11 |
27 |
RESPONSE TO HORMONE |
119 |
893 |
2.502e-13 |
4.312e-11 |
28 |
REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
105 |
750 |
3.156e-13 |
5.065e-11 |
29 |
NEGATIVE REGULATION OF CELL DIFFERENTIATION |
91 |
609 |
3.129e-13 |
5.065e-11 |
30 |
LOCOMOTION |
139 |
1114 |
3.658e-13 |
5.674e-11 |
31 |
CELLULAR RESPONSE TO NITROGEN COMPOUND |
80 |
505 |
4.075e-13 |
6.116e-11 |
32 |
NEURON DEVELOPMENT |
98 |
687 |
6.55e-13 |
9.524e-11 |
33 |
NEURON PROJECTION MORPHOGENESIS |
68 |
402 |
1.121e-12 |
1.581e-10 |
34 |
NEURON PROJECTION DEVELOPMENT |
83 |
545 |
1.284e-12 |
1.757e-10 |
35 |
CELL CELL ADHESION |
89 |
608 |
1.859e-12 |
2.472e-10 |
36 |
CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION |
63 |
368 |
4.494e-12 |
5.809e-10 |
37 |
CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND |
106 |
799 |
7.262e-12 |
9.086e-10 |
38 |
RESPONSE TO ORGANIC CYCLIC COMPOUND |
117 |
917 |
7.421e-12 |
9.086e-10 |
39 |
TISSUE DEVELOPMENT |
170 |
1518 |
8.435e-12 |
1.006e-09 |
40 |
POSITIVE REGULATION OF BIOSYNTHETIC PROCESS |
194 |
1805 |
9.545e-12 |
1.075e-09 |
41 |
CELL MOTILITY |
109 |
835 |
9.933e-12 |
1.075e-09 |
42 |
LOCALIZATION OF CELL |
109 |
835 |
9.933e-12 |
1.075e-09 |
43 |
RESPONSE TO OXYGEN CONTAINING COMPOUND |
158 |
1381 |
9.735e-12 |
1.075e-09 |
44 |
VASCULATURE DEVELOPMENT |
73 |
469 |
1.052e-11 |
1.113e-09 |
45 |
POSITIVE REGULATION OF GENE EXPRESSION |
187 |
1733 |
1.724e-11 |
1.783e-09 |
46 |
RESPONSE TO NITROGEN COMPOUND |
110 |
859 |
2.624e-11 |
2.654e-09 |
47 |
CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
76 |
513 |
4.538e-11 |
4.492e-09 |
48 |
REGULATION OF SYSTEM PROCESS |
75 |
507 |
6.554e-11 |
6.353e-09 |
49 |
POSITIVE REGULATION OF LOCOMOTION |
66 |
420 |
6.873e-11 |
6.527e-09 |
50 |
HEART DEVELOPMENT |
70 |
466 |
1.44e-10 |
1.34e-08 |
51 |
CELLULAR RESPONSE TO ORGANIC SUBSTANCE |
192 |
1848 |
2.312e-10 |
2.109e-08 |
52 |
FOREBRAIN DEVELOPMENT |
58 |
357 |
2.67e-10 |
2.389e-08 |
53 |
COGNITION |
46 |
251 |
3.559e-10 |
3.124e-08 |
54 |
REGULATION OF NEURON PROJECTION DEVELOPMENT |
63 |
408 |
3.896e-10 |
3.329e-08 |
55 |
HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES |
34 |
153 |
3.935e-10 |
3.329e-08 |
56 |
RESPONSE TO STEROID HORMONE |
72 |
497 |
4.118e-10 |
3.422e-08 |
57 |
REGULATION OF CELL PROJECTION ORGANIZATION |
78 |
558 |
4.229e-10 |
3.452e-08 |
58 |
REGULATION OF ION TRANSPORT |
81 |
592 |
5.492e-10 |
4.406e-08 |
59 |
CELLULAR RESPONSE TO HORMONE STIMULUS |
77 |
552 |
6.051e-10 |
4.772e-08 |
60 |
CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES |
40 |
204 |
6.368e-10 |
4.938e-08 |
61 |
MODULATION OF SYNAPTIC TRANSMISSION |
51 |
301 |
7.193e-10 |
5.487e-08 |
62 |
REGULATION OF TRANSPORT |
186 |
1804 |
8.613e-10 |
6.464e-08 |
63 |
REGULATION OF CELL PROLIFERATION |
160 |
1496 |
1.184e-09 |
8.746e-08 |
64 |
REGULATION OF MEMBRANE POTENTIAL |
55 |
343 |
1.266e-09 |
9.207e-08 |
65 |
BLOOD VESSEL MORPHOGENESIS |
57 |
364 |
1.575e-09 |
1.127e-07 |
66 |
POSITIVE REGULATION OF CELL DEVELOPMENT |
68 |
472 |
1.607e-09 |
1.133e-07 |
67 |
TAXIS |
67 |
464 |
1.928e-09 |
1.339e-07 |
68 |
CELL PROJECTION ORGANIZATION |
108 |
902 |
2.025e-09 |
1.386e-07 |
69 |
CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND |
67 |
465 |
2.11e-09 |
1.403e-07 |
70 |
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
117 |
1004 |
2.083e-09 |
1.403e-07 |
71 |
ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY |
88 |
689 |
3.171e-09 |
2.078e-07 |
72 |
NEGATIVE REGULATION OF GENE EXPRESSION |
158 |
1493 |
3.22e-09 |
2.081e-07 |
73 |
POSITIVE REGULATION OF CELL PROLIFERATION |
99 |
814 |
4.381e-09 |
2.755e-07 |
74 |
INTRACELLULAR SIGNAL TRANSDUCTION |
164 |
1572 |
4.348e-09 |
2.755e-07 |
75 |
NEURON PROJECTION GUIDANCE |
38 |
205 |
8.663e-09 |
5.375e-07 |
76 |
REGULATION OF CELL ADHESION |
81 |
629 |
9.402e-09 |
5.756e-07 |
77 |
NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS |
158 |
1517 |
9.712e-09 |
5.794e-07 |
78 |
REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY |
41 |
232 |
9.599e-09 |
5.794e-07 |
79 |
POSITIVE REGULATION OF NEURON DIFFERENTIATION |
49 |
306 |
1.053e-08 |
6.202e-07 |
80 |
CAMP METABOLIC PROCESS |
14 |
34 |
1.315e-08 |
7.649e-07 |
81 |
REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
52 |
337 |
1.361e-08 |
7.819e-07 |
82 |
CELLULAR COMPONENT MORPHOGENESIS |
105 |
900 |
1.381e-08 |
7.834e-07 |
83 |
POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
62 |
437 |
1.527e-08 |
8.562e-07 |
84 |
TELENCEPHALON DEVELOPMENT |
40 |
228 |
1.793e-08 |
9.93e-07 |
85 |
POSITIVE REGULATION OF MOLECULAR FUNCTION |
179 |
1791 |
1.929e-08 |
1.056e-06 |
86 |
POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION |
48 |
303 |
2.106e-08 |
1.14e-06 |
87 |
REGULATION OF MUSCLE SYSTEM PROCESS |
36 |
195 |
2.366e-08 |
1.266e-06 |
88 |
REGULATION OF OSSIFICATION |
34 |
178 |
2.398e-08 |
1.268e-06 |
89 |
ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS |
109 |
957 |
2.632e-08 |
1.376e-06 |
90 |
SKELETAL SYSTEM DEVELOPMENT |
63 |
455 |
2.973e-08 |
1.537e-06 |
91 |
UROGENITAL SYSTEM DEVELOPMENT |
47 |
299 |
3.768e-08 |
1.927e-06 |
92 |
REGULATION OF SYNAPTIC PLASTICITY |
29 |
140 |
3.996e-08 |
2.021e-06 |
93 |
PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS |
192 |
1977 |
4.754e-08 |
2.379e-06 |
94 |
NEGATIVE REGULATION OF CELL PROLIFERATION |
80 |
643 |
5.296e-08 |
2.622e-06 |
95 |
CELL PART MORPHOGENESIS |
79 |
633 |
5.629e-08 |
2.757e-06 |
96 |
DEVELOPMENTAL GROWTH |
50 |
333 |
6.28e-08 |
3.044e-06 |
97 |
REGULATION OF BLOOD CIRCULATION |
46 |
295 |
6.718e-08 |
3.222e-06 |
98 |
IMMUNE SYSTEM DEVELOPMENT |
74 |
582 |
7.004e-08 |
3.297e-06 |
99 |
REGULATION OF HEART CONTRACTION |
38 |
221 |
7.015e-08 |
3.297e-06 |
100 |
TUBE DEVELOPMENT |
71 |
552 |
8.198e-08 |
3.777e-06 |
101 |
REGULATION OF CELL MORPHOGENESIS |
71 |
552 |
8.198e-08 |
3.777e-06 |
102 |
SYNAPSE ORGANIZATION |
29 |
145 |
8.966e-08 |
4.09e-06 |
103 |
CYCLIC NUCLEOTIDE METABOLIC PROCESS |
17 |
57 |
1.047e-07 |
4.73e-06 |
104 |
NEGATIVE REGULATION OF LOCOMOTION |
42 |
263 |
1.263e-07 |
5.652e-06 |
105 |
POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
123 |
1152 |
1.291e-07 |
5.699e-06 |
106 |
MULTICELLULAR ORGANISMAL SIGNALING |
26 |
123 |
1.298e-07 |
5.699e-06 |
107 |
TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
86 |
724 |
1.349e-07 |
5.867e-06 |
108 |
NEGATIVE REGULATION OF RESPONSE TO STIMULUS |
140 |
1360 |
1.489e-07 |
6.357e-06 |
109 |
CELLULAR RESPONSE TO PEPTIDE |
43 |
274 |
1.487e-07 |
6.357e-06 |
110 |
NEGATIVE REGULATION OF CELL DEVELOPMENT |
46 |
303 |
1.51e-07 |
6.388e-06 |
111 |
PROTEIN PHOSPHORYLATION |
105 |
944 |
1.583e-07 |
6.636e-06 |
112 |
EPITHELIUM DEVELOPMENT |
105 |
945 |
1.668e-07 |
6.894e-06 |
113 |
CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION |
31 |
166 |
1.674e-07 |
6.894e-06 |
114 |
NEURON MIGRATION |
24 |
110 |
2.099e-07 |
8.568e-06 |
115 |
POSITIVE REGULATION OF CATALYTIC ACTIVITY |
152 |
1518 |
2.332e-07 |
9.435e-06 |
116 |
REGULATION OF PHOSPHORUS METABOLIC PROCESS |
160 |
1618 |
2.397e-07 |
9.615e-06 |
117 |
ADULT BEHAVIOR |
27 |
135 |
2.469e-07 |
9.821e-06 |
118 |
REGULATION OF DEVELOPMENTAL GROWTH |
44 |
289 |
2.579e-07 |
1.004e-05 |
119 |
POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
112 |
1036 |
2.61e-07 |
1.004e-05 |
120 |
POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
112 |
1036 |
2.61e-07 |
1.004e-05 |
121 |
POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT |
38 |
232 |
2.566e-07 |
1.004e-05 |
122 |
REGULATION OF CELL DEATH |
148 |
1472 |
2.677e-07 |
1.021e-05 |
123 |
PALLIUM DEVELOPMENT |
29 |
153 |
2.993e-07 |
1.124e-05 |
124 |
REGULATION OF OSTEOBLAST DIFFERENTIATION |
24 |
112 |
2.995e-07 |
1.124e-05 |
125 |
MUSCLE STRUCTURE DEVELOPMENT |
58 |
432 |
3.028e-07 |
1.127e-05 |
126 |
RESPONSE TO OXYGEN LEVELS |
46 |
311 |
3.27e-07 |
1.208e-05 |
127 |
REGULATION OF ACTIN FILAMENT BASED PROCESS |
46 |
312 |
3.592e-07 |
1.316e-05 |
128 |
REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL |
16 |
55 |
3.625e-07 |
1.318e-05 |
129 |
ANGIOGENESIS |
44 |
293 |
3.82e-07 |
1.378e-05 |
130 |
POSITIVE REGULATION OF HYDROLASE ACTIVITY |
100 |
905 |
4.307e-07 |
1.53e-05 |
131 |
REGULATION OF TRANSMEMBRANE TRANSPORT |
57 |
426 |
4.283e-07 |
1.53e-05 |
132 |
POSITIVE REGULATION OF DEVELOPMENTAL GROWTH |
29 |
156 |
4.584e-07 |
1.616e-05 |
133 |
RESPONSE TO LIPID |
98 |
888 |
5.968e-07 |
2.088e-05 |
134 |
GROWTH |
55 |
410 |
6.27e-07 |
2.177e-05 |
135 |
SECOND MESSENGER MEDIATED SIGNALING |
29 |
160 |
7.933e-07 |
2.734e-05 |
136 |
LEUKOCYTE DIFFERENTIATION |
43 |
292 |
8.854e-07 |
3.029e-05 |
137 |
TISSUE MORPHOGENESIS |
66 |
533 |
9.274e-07 |
3.15e-05 |
138 |
REGULATION OF MUSCLE TISSUE DEVELOPMENT |
22 |
103 |
9.792e-07 |
3.302e-05 |
139 |
NEGATIVE REGULATION OF NEURON DEATH |
30 |
171 |
1.055e-06 |
3.531e-05 |
140 |
ORGAN MORPHOGENESIS |
93 |
841 |
1.068e-06 |
3.551e-05 |
141 |
RESPONSE TO ESTROGEN |
35 |
218 |
1.218e-06 |
4.019e-05 |
142 |
LYMPHOCYTE DIFFERENTIATION |
34 |
209 |
1.266e-06 |
4.15e-05 |
143 |
NEGATIVE REGULATION OF CELL COMMUNICATION |
122 |
1192 |
1.342e-06 |
4.367e-05 |
144 |
EMBRYONIC MORPHOGENESIS |
66 |
539 |
1.375e-06 |
4.413e-05 |
145 |
REGULATION OF GTPASE ACTIVITY |
78 |
673 |
1.369e-06 |
4.413e-05 |
146 |
RESPONSE TO MONOAMINE |
12 |
35 |
1.506e-06 |
4.8e-05 |
147 |
RHYTHMIC PROCESS |
43 |
298 |
1.536e-06 |
4.863e-05 |
148 |
REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
159 |
1656 |
1.583e-06 |
4.976e-05 |
149 |
REGULATION OF FAT CELL DIFFERENTIATION |
22 |
106 |
1.634e-06 |
5.103e-05 |
150 |
TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY |
62 |
498 |
1.649e-06 |
5.117e-05 |
151 |
LEARNING |
25 |
131 |
1.692e-06 |
5.213e-05 |
152 |
RESPONSE TO PEPTIDE |
53 |
404 |
1.977e-06 |
5.974e-05 |
153 |
SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION |
53 |
404 |
1.977e-06 |
5.974e-05 |
154 |
RESPONSE TO ALCOHOL |
49 |
362 |
1.958e-06 |
5.974e-05 |
155 |
POSITIVE REGULATION OF OSSIFICATION |
19 |
84 |
2.14e-06 |
6.425e-05 |
156 |
MUSCLE SYSTEM PROCESS |
41 |
282 |
2.199e-06 |
6.557e-05 |
157 |
REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION |
21 |
100 |
2.294e-06 |
6.798e-05 |
158 |
TUBE MORPHOGENESIS |
45 |
323 |
2.335e-06 |
6.878e-05 |
159 |
REGULATION OF HEMOPOIESIS |
44 |
314 |
2.582e-06 |
7.556e-05 |
160 |
POSITIVE REGULATION OF CELL COMMUNICATION |
148 |
1532 |
2.691e-06 |
7.778e-05 |
161 |
REGULATION OF MUSCLE ADAPTATION |
16 |
63 |
2.683e-06 |
7.778e-05 |
162 |
REGULATION OF METAL ION TRANSPORT |
45 |
325 |
2.762e-06 |
7.892e-05 |
163 |
REGULATION OF PROTEIN MODIFICATION PROCESS |
162 |
1710 |
2.765e-06 |
7.892e-05 |
164 |
CAMP MEDIATED SIGNALING |
12 |
37 |
2.95e-06 |
8.37e-05 |
165 |
MORPHOGENESIS OF AN EPITHELIUM |
52 |
400 |
3.225e-06 |
9.038e-05 |
166 |
ACTION POTENTIAL |
20 |
94 |
3.208e-06 |
9.038e-05 |
167 |
REGULATION OF NEUROTRANSMITTER LEVELS |
31 |
190 |
3.448e-06 |
9.608e-05 |
168 |
LOCOMOTORY BEHAVIOR |
30 |
181 |
3.551e-06 |
9.835e-05 |
169 |
NEGATIVE REGULATION OF NEURON DIFFERENTIATION |
31 |
191 |
3.857e-06 |
0.0001062 |
170 |
RESPONSE TO MECHANICAL STIMULUS |
33 |
210 |
3.925e-06 |
0.0001074 |
171 |
RESPONSE TO KETONE |
30 |
182 |
3.984e-06 |
0.0001084 |
172 |
RESPONSE TO ESTRADIOL |
26 |
146 |
4.069e-06 |
0.0001101 |
173 |
POSITIVE REGULATION OF FAT CELL DIFFERENTIATION |
14 |
51 |
4.164e-06 |
0.000112 |
174 |
REGULATION OF HOMEOSTATIC PROCESS |
56 |
447 |
4.305e-06 |
0.0001151 |
175 |
DEVELOPMENTAL MATURATION |
31 |
193 |
4.813e-06 |
0.000128 |
176 |
CELL CELL SIGNALING |
84 |
767 |
5.206e-06 |
0.0001376 |
177 |
REGULATION OF ANATOMICAL STRUCTURE SIZE |
58 |
472 |
5.331e-06 |
0.0001401 |
178 |
MULTI MULTICELLULAR ORGANISM PROCESS |
33 |
213 |
5.365e-06 |
0.0001402 |
179 |
NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
38 |
262 |
5.414e-06 |
0.0001407 |
180 |
CYCLIC NUCLEOTIDE CATABOLIC PROCESS |
8 |
17 |
5.536e-06 |
0.0001431 |
181 |
RESPONSE TO EXTERNAL STIMULUS |
169 |
1821 |
5.623e-06 |
0.0001445 |
182 |
CARDIAC CONDUCTION |
18 |
82 |
6.191e-06 |
0.0001579 |
183 |
T CELL DIFFERENTIATION |
23 |
123 |
6.212e-06 |
0.0001579 |
184 |
MEMORY |
20 |
98 |
6.286e-06 |
0.000159 |
185 |
CYCLIC NUCLEOTIDE MEDIATED SIGNALING |
13 |
46 |
6.437e-06 |
0.0001619 |
186 |
REGULATION OF EPITHELIAL CELL PROLIFERATION |
40 |
285 |
6.983e-06 |
0.0001747 |
187 |
ARTERY DEVELOPMENT |
17 |
75 |
7.052e-06 |
0.0001755 |
188 |
RIBONUCLEOTIDE CATABOLIC PROCESS |
10 |
28 |
7.479e-06 |
0.0001851 |
189 |
CELL ACTIVATION |
66 |
568 |
8.134e-06 |
0.0002002 |
190 |
REGULATION OF HYDROLASE ACTIVITY |
129 |
1327 |
9.139e-06 |
0.0002238 |
191 |
POSITIVE REGULATION OF GROWTH |
35 |
238 |
9.224e-06 |
0.0002247 |
192 |
PHOSPHORYLATION |
121 |
1228 |
9.404e-06 |
0.0002279 |
193 |
NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS |
24 |
135 |
9.716e-06 |
0.0002283 |
194 |
POSITIVE REGULATION OF RESPONSE TO STIMULUS |
176 |
1929 |
9.715e-06 |
0.0002283 |
195 |
SINGLE ORGANISM CELL ADHESION |
56 |
459 |
9.538e-06 |
0.0002283 |
196 |
MESENCHYME DEVELOPMENT |
30 |
190 |
9.644e-06 |
0.0002283 |
197 |
STEM CELL DIFFERENTIATION |
30 |
190 |
9.644e-06 |
0.0002283 |
198 |
POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
27 |
162 |
9.655e-06 |
0.0002283 |
199 |
REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
34 |
229 |
1e-05 |
0.0002338 |
200 |
ACTIN FILAMENT BASED PROCESS |
55 |
450 |
1.085e-05 |
0.0002524 |
201 |
REGULATION OF CELL SUBSTRATE ADHESION |
28 |
173 |
1.177e-05 |
0.0002724 |
202 |
REGULATION OF NEURON APOPTOTIC PROCESS |
30 |
192 |
1.191e-05 |
0.0002743 |
203 |
RESPONSE TO GROWTH FACTOR |
57 |
475 |
1.305e-05 |
0.000299 |
204 |
REGULATION OF LEUKOCYTE DIFFERENTIATION |
34 |
232 |
1.326e-05 |
0.0002999 |
205 |
MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL |
7 |
14 |
1.334e-05 |
0.0002999 |
206 |
REGULATION OF NEURON DEATH |
36 |
252 |
1.332e-05 |
0.0002999 |
207 |
CAMP CATABOLIC PROCESS |
7 |
14 |
1.334e-05 |
0.0002999 |
208 |
REGULATION OF CIRCADIAN RHYTHM |
20 |
103 |
1.376e-05 |
0.0003048 |
209 |
POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION |
20 |
103 |
1.376e-05 |
0.0003048 |
210 |
REGULATION OF MUSCLE ORGAN DEVELOPMENT |
20 |
103 |
1.376e-05 |
0.0003048 |
211 |
REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
24 |
138 |
1.427e-05 |
0.0003147 |
212 |
NEGATIVE REGULATION OF CELL ADHESION |
33 |
223 |
1.44e-05 |
0.000316 |
213 |
REGULATION OF EPITHELIAL CELL MIGRATION |
27 |
166 |
1.527e-05 |
0.0003336 |
214 |
REGULATION OF NEUROTRANSMITTER TRANSPORT |
15 |
64 |
1.574e-05 |
0.0003423 |
215 |
ADULT LOCOMOTORY BEHAVIOR |
17 |
80 |
1.755e-05 |
0.0003797 |
216 |
RESPONSE TO PURINE CONTAINING COMPOUND |
26 |
158 |
1.767e-05 |
0.0003807 |
217 |
LEUKOCYTE ACTIVATION |
51 |
414 |
1.811e-05 |
0.0003883 |
218 |
CEREBRAL CORTEX DEVELOPMENT |
20 |
105 |
1.851e-05 |
0.0003951 |
219 |
POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
112 |
1135 |
1.921e-05 |
0.0004081 |
220 |
CELLULAR RESPONSE TO KETONE |
16 |
73 |
2.046e-05 |
0.0004327 |
221 |
CELL FATE COMMITMENT |
33 |
227 |
2.091e-05 |
0.0004402 |
222 |
NEPHRON DEVELOPMENT |
21 |
115 |
2.257e-05 |
0.0004731 |
223 |
LYMPHOCYTE ACTIVATION |
44 |
342 |
2.329e-05 |
0.0004859 |
224 |
REGULATION OF MUSCLE CELL DIFFERENTIATION |
25 |
152 |
2.566e-05 |
0.0005331 |
225 |
POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT |
11 |
38 |
2.579e-05 |
0.0005334 |
226 |
POSITIVE REGULATION OF CELL ADHESION |
47 |
376 |
2.628e-05 |
0.000541 |
227 |
KIDNEY EPITHELIUM DEVELOPMENT |
22 |
125 |
2.646e-05 |
0.0005423 |
228 |
RESPONSE TO DRUG |
52 |
431 |
2.665e-05 |
0.0005438 |
229 |
POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION |
15 |
67 |
2.823e-05 |
0.0005736 |
230 |
POSITIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING |
6 |
11 |
3.057e-05 |
0.0006158 |
231 |
REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING |
6 |
11 |
3.057e-05 |
0.0006158 |
232 |
POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION |
14 |
60 |
3.168e-05 |
0.0006355 |
233 |
REGULATION OF CELLULAR COMPONENT SIZE |
43 |
337 |
3.501e-05 |
0.0006991 |
234 |
REGULATION OF VASCULATURE DEVELOPMENT |
33 |
233 |
3.579e-05 |
0.0007116 |
235 |
CELLULAR RESPONSE TO INSULIN STIMULUS |
24 |
146 |
3.729e-05 |
0.0007383 |
236 |
SENSORY ORGAN DEVELOPMENT |
57 |
493 |
3.819e-05 |
0.000753 |
237 |
MUSCLE TISSUE DEVELOPMENT |
37 |
275 |
3.884e-05 |
0.0007626 |
238 |
NEGATIVE REGULATION OF OSSIFICATION |
15 |
69 |
4.079e-05 |
0.0007975 |
239 |
REGULATION OF GROWTH |
69 |
633 |
4.168e-05 |
0.0008114 |
240 |
NEGATIVE REGULATION OF CELL DEATH |
89 |
872 |
4.186e-05 |
0.0008116 |
241 |
REGULATION OF CELL ACTIVATION |
56 |
484 |
4.364e-05 |
0.0008418 |
242 |
NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION |
11 |
40 |
4.378e-05 |
0.0008418 |
243 |
EMBRYONIC ORGAN DEVELOPMENT |
49 |
406 |
4.464e-05 |
0.0008547 |
244 |
MUSCLE ORGAN DEVELOPMENT |
37 |
277 |
4.545e-05 |
0.0008667 |
245 |
CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT |
15 |
70 |
4.874e-05 |
0.0009257 |
246 |
REGULATION OF CELLULAR COMPONENT BIOGENESIS |
80 |
767 |
4.915e-05 |
0.0009297 |
247 |
REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
30 |
207 |
5.163e-05 |
0.0009727 |
248 |
POSITIVE REGULATION OF PHOSPHATASE ACTIVITY |
9 |
28 |
5.638e-05 |
0.001058 |
249 |
REGULATION OF CALCIUM ION TRANSPORT |
30 |
209 |
6.189e-05 |
0.001157 |
250 |
REGULATION OF CHEMOTAXIS |
27 |
180 |
6.608e-05 |
0.00123 |
251 |
REGULATION OF SMOOTH MUSCLE CELL MIGRATION |
12 |
49 |
6.948e-05 |
0.001288 |
252 |
POSITIVE REGULATION OF PURINE NUCLEOTIDE METABOLIC PROCESS |
22 |
133 |
7.026e-05 |
0.001292 |
253 |
POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS |
22 |
133 |
7.026e-05 |
0.001292 |
254 |
EXTRACELLULAR STRUCTURE ORGANIZATION |
39 |
304 |
7.055e-05 |
0.001292 |
255 |
INOSITOL LIPID MEDIATED SIGNALING |
21 |
124 |
7.169e-05 |
0.001308 |
256 |
POSITIVE REGULATION OF CAMP METABOLIC PROCESS |
17 |
89 |
7.398e-05 |
0.001339 |
257 |
REGULATION OF NUCLEOTIDE METABOLIC PROCESS |
30 |
211 |
7.395e-05 |
0.001339 |
258 |
REGULATION OF ORGAN MORPHOGENESIS |
33 |
242 |
7.647e-05 |
0.001379 |
259 |
MESENCHYMAL CELL DIFFERENTIATION |
22 |
134 |
7.884e-05 |
0.001416 |
260 |
MUSCLE CONTRACTION |
32 |
233 |
8.506e-05 |
0.001522 |
261 |
MESONEPHROS DEVELOPMENT |
17 |
90 |
8.56e-05 |
0.001526 |
262 |
CELL PROLIFERATION |
71 |
672 |
8.697e-05 |
0.001544 |
263 |
POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC |
7 |
18 |
9.752e-05 |
0.001712 |
264 |
CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS |
7 |
18 |
9.752e-05 |
0.001712 |
265 |
RESPONSE TO CAFFEINE |
7 |
18 |
9.752e-05 |
0.001712 |
266 |
GASTRULATION |
24 |
155 |
9.93e-05 |
0.001737 |
267 |
EMBRYO DEVELOPMENT |
89 |
894 |
0.0001022 |
0.00178 |
268 |
CELLULAR RESPONSE TO ACID CHEMICAL |
26 |
175 |
0.0001051 |
0.001825 |
269 |
POSITIVE REGULATION OF CELL DEATH |
65 |
605 |
0.0001056 |
0.001827 |
270 |
EAR DEVELOPMENT |
28 |
195 |
0.0001066 |
0.001836 |
271 |
CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS |
8 |
24 |
0.0001098 |
0.001885 |
272 |
RESPONSE TO ALKALOID |
22 |
137 |
0.0001104 |
0.001889 |
273 |
POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS |
136 |
1492 |
0.0001138 |
0.001938 |
274 |
CARDIAC MUSCLE CELL ACTION POTENTIAL |
10 |
37 |
0.0001141 |
0.001938 |
275 |
MUSCLE CELL DIFFERENTIATION |
32 |
237 |
0.0001177 |
0.001992 |
276 |
CELLULAR RESPONSE TO LIPID |
52 |
457 |
0.0001237 |
0.002085 |
277 |
MORPHOGENESIS OF A BRANCHING STRUCTURE |
25 |
167 |
0.0001252 |
0.002102 |
278 |
RESPONSE TO ABIOTIC STIMULUS |
99 |
1024 |
0.0001272 |
0.00213 |
279 |
SYNAPTIC SIGNALING |
49 |
424 |
0.0001318 |
0.002198 |
280 |
REGULATION OF RESPONSE TO WOUNDING |
48 |
413 |
0.0001342 |
0.002229 |
281 |
CELLULAR RESPONSE TO STEROID HORMONE STIMULUS |
30 |
218 |
0.0001346 |
0.002229 |
282 |
POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION |
13 |
60 |
0.000136 |
0.002244 |
283 |
REGULATION OF CATION TRANSMEMBRANE TRANSPORT |
29 |
208 |
0.0001373 |
0.002257 |
284 |
PALATE DEVELOPMENT |
16 |
85 |
0.0001429 |
0.002341 |
285 |
CELLULAR RESPONSE TO GLUCAGON STIMULUS |
10 |
38 |
0.0001457 |
0.002378 |
286 |
RESPONSE TO PROSTAGLANDIN E |
8 |
25 |
0.000152 |
0.002465 |
287 |
RESPONSE TO AMINO ACID |
19 |
112 |
0.000152 |
0.002465 |
288 |
POSITIVE REGULATION OF FATTY ACID OXIDATION |
6 |
14 |
0.0001668 |
0.002695 |
289 |
GLAND DEVELOPMENT |
46 |
395 |
0.0001751 |
0.002819 |
290 |
PROTEIN LOCALIZATION TO CELL PERIPHERY |
23 |
151 |
0.0001765 |
0.002823 |
291 |
NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
35 |
274 |
0.0001765 |
0.002823 |
292 |
REGULATION OF PHOSPHOLIPASE C ACTIVITY |
10 |
39 |
0.0001842 |
0.002896 |
293 |
MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL |
10 |
39 |
0.0001842 |
0.002896 |
294 |
ACTIVATION OF ADENYLATE CYCLASE ACTIVITY |
10 |
39 |
0.0001842 |
0.002896 |
295 |
REGULATION OF AXON GUIDANCE |
10 |
39 |
0.0001842 |
0.002896 |
296 |
WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY |
10 |
39 |
0.0001842 |
0.002896 |
297 |
REGULATION OF ENDOTHELIAL CELL MIGRATION |
19 |
114 |
0.0001931 |
0.003015 |
298 |
POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
13 |
62 |
0.000193 |
0.003015 |
299 |
RESPONSE TO ACID CHEMICAL |
39 |
319 |
0.0001971 |
0.003067 |
300 |
CYTOSKELETON ORGANIZATION |
83 |
838 |
0.0002053 |
0.003185 |
301 |
POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
86 |
876 |
0.0002125 |
0.003284 |
302 |
POSITIVE REGULATION OF DEPHOSPHORYLATION |
11 |
47 |
0.000214 |
0.003297 |
303 |
POSITIVE REGULATION OF HEMOPOIESIS |
24 |
163 |
0.000219 |
0.003364 |
304 |
ADHERENS JUNCTION ORGANIZATION |
14 |
71 |
0.0002204 |
0.003374 |
305 |
NEURON RECOGNITION |
9 |
33 |
0.0002323 |
0.00352 |
306 |
CIRCULATORY SYSTEM PROCESS |
43 |
366 |
0.0002317 |
0.00352 |
307 |
NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION |
22 |
144 |
0.0002314 |
0.00352 |
308 |
POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
23 |
154 |
0.0002375 |
0.003587 |
309 |
POSITIVE REGULATION OF MAPK CASCADE |
52 |
470 |
0.000248 |
0.003735 |
310 |
EMBRYONIC ORGAN MORPHOGENESIS |
35 |
279 |
0.0002507 |
0.003763 |
311 |
ADENYLATE CYCLASE MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY |
22 |
145 |
0.0002559 |
0.003829 |
312 |
POSITIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY |
6 |
15 |
0.0002623 |
0.003862 |
313 |
REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT |
11 |
48 |
0.000261 |
0.003862 |
314 |
POSITIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY |
11 |
48 |
0.000261 |
0.003862 |
315 |
RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION |
6 |
15 |
0.0002623 |
0.003862 |
316 |
REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY |
6 |
15 |
0.0002623 |
0.003862 |
317 |
SYSTEM PROCESS |
156 |
1785 |
0.000271 |
0.003978 |
318 |
REGULATION OF CELL CELL ADHESION |
44 |
380 |
0.000272 |
0.00398 |
319 |
REGULATION OF ASTROCYTE DIFFERENTIATION |
8 |
27 |
0.0002767 |
0.004036 |
320 |
CALCIUM MEDIATED SIGNALING |
16 |
90 |
0.0002844 |
0.004122 |
321 |
REGULATION OF CELLULAR LOCALIZATION |
117 |
1277 |
0.0002841 |
0.004122 |
322 |
LIPID PHOSPHORYLATION |
17 |
99 |
0.000286 |
0.004132 |
323 |
RESPONSE TO CORTICOSTEROID |
25 |
176 |
0.0002886 |
0.004144 |
324 |
BONE DEVELOPMENT |
23 |
156 |
0.0002877 |
0.004144 |
325 |
RESPONSE TO PROSTAGLANDIN |
9 |
34 |
0.0002973 |
0.00425 |
326 |
HIPPOCAMPUS DEVELOPMENT |
14 |
73 |
0.0002987 |
0.00425 |
327 |
ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY |
14 |
73 |
0.0002987 |
0.00425 |
328 |
MESODERM DEVELOPMENT |
19 |
118 |
0.0003052 |
0.00433 |
329 |
REGULATION OF MUSCLE CONTRACTION |
22 |
147 |
0.0003118 |
0.00441 |
330 |
POSITIVE REGULATION OF CYCLIC NUCLEOTIDE METABOLIC PROCESS |
18 |
109 |
0.0003166 |
0.004464 |
331 |
LIMBIC SYSTEM DEVELOPMENT |
17 |
100 |
0.0003234 |
0.004546 |
332 |
REGULATION OF PEPTIDE SECRETION |
28 |
209 |
0.0003472 |
0.004852 |
333 |
REGULATION OF AXONOGENESIS |
24 |
168 |
0.000347 |
0.004852 |
334 |
REGULATION OF POTASSIUM ION TRANSPORT |
15 |
83 |
0.0003626 |
0.005052 |
335 |
REGULATION OF FATTY ACID OXIDATION |
8 |
28 |
0.0003648 |
0.005055 |
336 |
REGULATION OF EXTENT OF CELL GROWTH |
17 |
101 |
0.0003651 |
0.005055 |
337 |
REGULATION OF HOMOTYPIC CELL CELL ADHESION |
37 |
307 |
0.0003755 |
0.005184 |
338 |
REGULATION OF GASTRULATION |
9 |
35 |
0.0003767 |
0.005185 |
339 |
REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC |
11 |
50 |
0.0003815 |
0.005194 |
340 |
REGULATION OF CYTOSKELETON ORGANIZATION |
54 |
502 |
0.0003817 |
0.005194 |
341 |
PURINE CONTAINING COMPOUND CATABOLIC PROCESS |
11 |
50 |
0.0003815 |
0.005194 |
342 |
REGULATION OF DENDRITE DEVELOPMENT |
19 |
120 |
0.00038 |
0.005194 |
343 |
RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE |
6 |
16 |
0.000396 |
0.005356 |
344 |
RESPONSE TO EPINEPHRINE |
6 |
16 |
0.000396 |
0.005356 |
345 |
NEURAL CREST CELL DIFFERENTIATION |
14 |
75 |
0.0003997 |
0.005391 |
346 |
CARDIAC MUSCLE TISSUE DEVELOPMENT |
21 |
140 |
0.0004096 |
0.005508 |
347 |
RENAL SYSTEM PROCESS |
17 |
102 |
0.0004113 |
0.005515 |
348 |
NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
69 |
684 |
0.000416 |
0.005562 |
349 |
MULTICELLULAR ORGANISM METABOLIC PROCESS |
16 |
93 |
0.0004176 |
0.005567 |
350 |
REGULATION OF MAPK CASCADE |
67 |
660 |
0.0004223 |
0.005614 |
351 |
REGULATION OF GLYCOPROTEIN METABOLIC PROCESS |
10 |
43 |
0.000435 |
0.005767 |
352 |
HEART MORPHOGENESIS |
28 |
212 |
0.0004387 |
0.005799 |
353 |
CELL MATURATION |
20 |
131 |
0.0004407 |
0.005809 |
354 |
NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
57 |
541 |
0.0004492 |
0.005888 |
355 |
NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
57 |
541 |
0.0004492 |
0.005888 |
356 |
REGENERATION |
23 |
161 |
0.0004564 |
0.005961 |
357 |
CELLULAR RESPONSE TO FATTY ACID |
11 |
51 |
0.0004574 |
0.005961 |
358 |
MULTICELLULAR ORGANISM GROWTH |
14 |
76 |
0.0004603 |
0.005982 |
359 |
EMBRYONIC SKELETAL SYSTEM DEVELOPMENT |
19 |
122 |
0.0004703 |
0.006096 |
360 |
NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT |
9 |
36 |
0.0004727 |
0.006109 |
361 |
EPITHELIAL CELL DIFFERENTIATION |
53 |
495 |
0.0004807 |
0.006196 |
362 |
REGULATION OF LYMPHOCYTE DIFFERENTIATION |
20 |
132 |
0.0004873 |
0.006264 |
363 |
PLASMA MEMBRANE ORGANIZATION |
27 |
203 |
0.0004924 |
0.006298 |
364 |
G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER |
24 |
172 |
0.0004927 |
0.006298 |
365 |
RESPONSE TO CAMP |
17 |
104 |
0.0005189 |
0.006615 |
366 |
REGULATION OF MYELOID CELL DIFFERENTIATION |
25 |
183 |
0.0005245 |
0.006669 |
367 |
REGULATION OF BMP SIGNALING PATHWAY |
14 |
77 |
0.0005285 |
0.0067 |
368 |
POSITIVE REGULATION OF VASCULATURE DEVELOPMENT |
20 |
133 |
0.0005383 |
0.006769 |
369 |
STRIATED MUSCLE CELL DIFFERENTIATION |
24 |
173 |
0.0005366 |
0.006769 |
370 |
REGULATION OF HEART RATE |
15 |
86 |
0.0005379 |
0.006769 |
371 |
TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER |
22 |
153 |
0.0005486 |
0.006881 |
372 |
CONNECTIVE TISSUE DEVELOPMENT |
26 |
194 |
0.0005519 |
0.006903 |
373 |
REGULATION OF EMBRYONIC DEVELOPMENT |
18 |
114 |
0.000554 |
0.006911 |
374 |
PROTEIN TARGETING TO PLASMA MEMBRANE |
7 |
23 |
0.0005587 |
0.006933 |
375 |
NEUROTROPHIN SIGNALING PATHWAY |
7 |
23 |
0.0005587 |
0.006933 |
376 |
NEGATIVE REGULATION OF PLATELET ACTIVATION |
6 |
17 |
0.0005775 |
0.007071 |
377 |
REGULATION OF PLATELET AGGREGATION |
6 |
17 |
0.0005775 |
0.007071 |
378 |
SYNAPTIC VESICLE ENDOCYTOSIS |
6 |
17 |
0.0005775 |
0.007071 |
379 |
RESPONSE TO INSULIN |
27 |
205 |
0.0005748 |
0.007071 |
380 |
POSITIVE REGULATION OF MRNA 3 END PROCESSING |
6 |
17 |
0.0005775 |
0.007071 |
381 |
POSITIVE REGULATION OF AXONOGENESIS |
13 |
69 |
0.0005806 |
0.007072 |
382 |
SYNAPSE ASSEMBLY |
13 |
69 |
0.0005806 |
0.007072 |
383 |
CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION |
9 |
37 |
0.0005879 |
0.007124 |
384 |
REGULATION OF MUSCLE HYPERTROPHY |
9 |
37 |
0.0005879 |
0.007124 |
385 |
DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS |
28 |
216 |
0.0005934 |
0.007172 |
386 |
POTASSIUM ION TRANSPORT |
22 |
154 |
0.0006005 |
0.007191 |
387 |
AMEBOIDAL TYPE CELL MIGRATION |
22 |
154 |
0.0006005 |
0.007191 |
388 |
RESPONSE TO TRANSFORMING GROWTH FACTOR BETA |
21 |
144 |
0.0006006 |
0.007191 |
389 |
CARDIOCYTE DIFFERENTIATION |
16 |
96 |
0.0006012 |
0.007191 |
390 |
RENAL TUBULE DEVELOPMENT |
14 |
78 |
0.0006051 |
0.007219 |
391 |
CELL JUNCTION ORGANIZATION |
25 |
185 |
0.0006174 |
0.007347 |
392 |
NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS |
42 |
372 |
0.0006239 |
0.007405 |
393 |
HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES |
10 |
45 |
0.0006407 |
0.007566 |
394 |
STEROID HORMONE MEDIATED SIGNALING PATHWAY |
19 |
125 |
0.0006404 |
0.007566 |
395 |
SPINAL CORD DEVELOPMENT |
17 |
106 |
0.00065 |
0.007638 |
396 |
FAT CELL DIFFERENTIATION |
17 |
106 |
0.00065 |
0.007638 |
397 |
SENSORY PERCEPTION OF MECHANICAL STIMULUS |
22 |
155 |
0.0006565 |
0.007676 |
398 |
REGULATION OF CYCLIC NUCLEOTIDE METABOLIC PROCESS |
22 |
155 |
0.0006565 |
0.007676 |
399 |
NEURAL PRECURSOR CELL PROLIFERATION |
13 |
70 |
0.0006701 |
0.007795 |
400 |
PEPTIDYL TYROSINE MODIFICATION |
25 |
186 |
0.000669 |
0.007795 |
401 |
REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT |
18 |
116 |
0.0006851 |
0.007949 |
402 |
RESPIRATORY SYSTEM DEVELOPMENT |
26 |
197 |
0.0006976 |
0.008075 |
403 |
RESPONSE TO WOUNDING |
58 |
563 |
0.0007017 |
0.008101 |
404 |
NEGATIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS |
5 |
12 |
0.0007079 |
0.008133 |
405 |
CELLULAR RESPONSE TO EPINEPHRINE STIMULUS |
5 |
12 |
0.0007079 |
0.008133 |
406 |
NEGATIVE REGULATION OF RESPONSE TO WOUNDING |
22 |
156 |
0.0007171 |
0.008218 |
407 |
FOREBRAIN CELL MIGRATION |
12 |
62 |
0.0007265 |
0.008287 |
408 |
SECRETION |
60 |
588 |
0.0007267 |
0.008287 |
409 |
NEGATIVE REGULATION OF PHOSPHORYLATION |
46 |
422 |
0.0007561 |
0.008602 |
410 |
HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION |
16 |
98 |
0.0007588 |
0.008605 |
411 |
NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
18 |
117 |
0.00076 |
0.008605 |
412 |
REGULATION OF PLATELET ACTIVATION |
8 |
31 |
0.0007737 |
0.008738 |
413 |
POST EMBRYONIC DEVELOPMENT |
15 |
89 |
0.0007808 |
0.008797 |
414 |
CIRCADIAN RHYTHM |
20 |
137 |
0.0007907 |
0.008866 |
415 |
HINDBRAIN DEVELOPMENT |
20 |
137 |
0.0007907 |
0.008866 |
416 |
POSITIVE REGULATION OF KINASE ACTIVITY |
51 |
482 |
0.0007957 |
0.008901 |
417 |
AGING |
32 |
264 |
0.0008192 |
0.00914 |
418 |
REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
16 |
99 |
0.0008499 |
0.009438 |
419 |
REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS |
16 |
99 |
0.0008499 |
0.009438 |
420 |
DIGESTIVE SYSTEM DEVELOPMENT |
21 |
148 |
0.0008645 |
0.009578 |
421 |
ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE |
15 |
90 |
0.0008801 |
0.009727 |